Close Menu

NEW YORK (GenomeWeb) – CareDx said today that its preliminary fourth quarter revenues rose 85 percent to 88 percent year over year, thanks to an increase of about 115 percent in testing revenues during the quarter.

For the three months ended Dec. 31, 2018, the company expects revenues of $23.2 million to $23.5 million, compared with $12.5 million in the fourth quarter of 2017. Analysts are expecting revenues of $21.8 million for the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a letter, about two dozen researchers criticize the World Health Organization investigation into the origins of SARS-CoV-2 and call for a new inquiry, the Wall Street Journal reports.

National Geographic reports that nine great apes at the San Diego Zoo have been vaccinated against SARS-CoV-2.

Janet Woodcock, the acting commissioner of the US Food and Drug Administration, speaks with NPR about SARS-CoV-2 testing and vaccines in the US.

In Science this week: genetic study of kidney fibrosis implicates the SOX9-NAV3-YAP1 axis.